CSX Chief Financial Officer to Address JP Morgan Industrials Conference
08 mars 2023 10h00 HE
|
CSX Corporation
JACKSONVILLE, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Sean Pelkey, will address the 2023 JP Morgan Industrials...
Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco
09 janv. 2023 08h30 HE
|
Blue Water Vaccines Inc.
CINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address...
InnovAge Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
05 janv. 2023 08h00 HE
|
InnovAge
DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors,...
InflaRx Provides Update on Planned Phase III Study Design in Pyoderma Gangrenosum with Vilobelimab and Status of its EUA Application in Critically Ill COVID-19 Patients
05 janv. 2023 07h30 HE
|
InflaRx N.V.
Multi-national, randomized, controlled adaptive Phase III design for vilobelimab in ulcerative pyoderma gangrenosum (PG) Trial size to be adapted upon interim analysis with planned total patient...
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
04 janv. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles
03 janv. 2023 09h00 HE
|
leon-nanodrugs GmbH
LEON achieved superior accuracy in development of its proprietary reactor, facilitating exceptional inter-device reproducibility of particle size and distribution, and thus seamless process transfer,...
Revolution Medicines to Present at 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 07h00 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Abel Noser Finishes Year with an Impressive List of Achievements
29 déc. 2022 06h30 HE
|
Abel Noser
New York, NY, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Abel Noser Holdings, the market leader in institutional trade analytics and agency-only trading solutions, has many notable achievements to look back...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the 41st Annual J.P. Morgan Healthcare Conference
20 déc. 2022 16h15 HE
|
Mettler-Toledo, LLC
Columbus, OH, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the 41st Annual JP Morgan Healthcare Conference on...
Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco
13 déc. 2022 14h07 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...